- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Sep 13, 2024)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Sep 16, 2024 | T-1777-23 | CMC | Amgen Canada Inc Et Al V. Dr. Reddy's Laboratories Ltd. (Patent) | Toronto | 30 m |
| Sep 17, 2024 | T-2304-24 | MIIN | Indigo Books & Music Inc. V. John Doe 1 Dba Indigo Kills Kids Et Al (Copyright) | Ottawa | 1.5 h |
| Sep 17, 2024 | T-2405-23 | CMC | Bailey Metal Products Limited V. Dcm Metal Corp. (Patent) | Toronto | 30 m |
| Sep 18, 2024 | T-1517-21 | APM | Hudson's Bay Company Ulc V. Zellers Inc. Et Al. (Trade Mark) | Montréal | 3 h |
| Sep 18, 2024 | T-948-22 | M | The Governing Council Of The University Of Toronto Et Al. V. Easy Group Inc. (Copyright) | Toronto | 2 h |
| Sep 18, 2024 | T-959-23 | MED | Portes Et Fenã?tres Verdun Ltã?e C. Nordik Cash And Carry Inc. (Trade Mark) | Ottawa | 3 h |
| Sep 19, 2024 | T-1125-24 | M | Zoe International Distributing Inc. V. Vanpak Limited (Copyright) | Vancouver | 1 h |
| Sep 19, 2024 | T-1059-22 | CMC | Seylynn (north Shore) Development Limited Partnership V. Denna Homes Group (Trade Mark) | Edmonton | 30 m |
| Sep 20, 2024 | T-954-18 | CMC | Deeproot Green Infrastructure, Llc Et Al V. Greenblue Urban North America In (Patent) | Toronto | 1 h |
| Sep 20, 2024 | T-1257-22 | CMC | Bell Media Inc Et Al. V. Marshall Macciacchera Et Al (Copyright) | Ottawa | 1 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Oct 21, 2024 | T-1471-21 | Ge Renewable Energy Canada Inc V. Canmec Industrial Inc. Et Al. (Copyright) | Montréal | 10 d |
| Oct 28, 2024 | T-641-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Empagliflozin*) | Toronto | 16 d |
| Nov 6, 2024 | T-1471-21 | Ge Renewable Energy Canada Inc V. Canmec Industrial Inc. Et Al. (Copyright) | Montréal | 1 d |
| Nov 12, 2024 | T-786-21 | Flowchem Llc V. Liquidpower Specialty Products Inc. (Patent) | Toronto | 10 d |
| Nov 12, 2024 | T-1429-21 | Liquidpower Specialty Products Inc. V. Baker Hughes Canada Company Et Al. (Patent) | Toronto | 10 d |
| Nov 25, 2024 | T-206-21 | Yelda Haber Ve Gã?rsel Yayincilik A.s. V. Glwiz Inc. Et Al. (Copyright) | Toronto | 4 d |
| Nov 25, 2024 | T-641-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Empagliflozin*) | Ottawa | 3 d |
| Dec 2, 2024 | T-206-21 | Yelda Haber Ve Gã?rsel Yayincilik A.s. V. Glwiz Inc. Et Al. (Copyright) | Toronto | 3 d |
| Dec 2, 2024 | T-786-21 | Flowchem Llc V. Liquidpower Specialty Products Inc. (Patent) | Toronto | 2 d |
| Dec 2, 2024 | T-1624-17 | Mccain Foods Limited V. J.r. Simplot Company Et Al (Patent) | Toronto | 9 d |
| Dec 2, 2024 | T-1429-21 | Liquidpower Specialty Products Inc. V. Baker Hughes Canada Company Et Al. (Patent) | Toronto | 2 d |
| Dec 13, 2024 | T-206-21 | Yelda Haber Ve Gã?rsel Yayincilik A.s. V. Glwiz Inc. Et Al. (Copyright) | Toronto | 1 d |
| Dec 18, 2024 | T-1624-17 | Mccain Foods Limited V. J.r. Simplot Company Et Al (Patent) | Toronto | 2 d |
| Jan 20, 2025 | T-841-21 | Adeia Guides, Inc. V. Videotron Ltd. (Patent) | Toronto | 15 d |
| Jan 20, 2025 | T-1094-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 13 d |
| Jan 20, 2025 | T-1095-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 13 d |
| Jan 27, 2025 | T-1506-20 | Meridian Manufacturing Inc. V. Concept Industries Ltd. (Patent) | Winnipeg | 7 d |
| Feb 13, 2025 | T-1094-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 2 d |
| Feb 13, 2025 | T-1095-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 2 d |
| Feb 17, 2025 | T-841-21 | Adeia Guides, Inc. V. Videotron Ltd. (Patent) | Toronto | 3 d |
| Mar 3, 2025 | T-1039-23 | Emd Serono, A Division Of Emd Inc., Canada Et Al. V. Apotex Inc. (Patent) | Toronto | 8 d |
| Mar 17, 2025 | T-1726-21 | 2660722 Ontario Inc. Et Al. V. Pacific Smoke International Inc. Et Al. (unknown) | Toronto | 10 d |
| Mar 20, 2025 | T-1039-23 | Emd Serono, A Division Of Emd Inc., Canada Et Al. V. Apotex Inc. (Patent) | Toronto | 1 d |
| Apr 28, 2025 | T-1288-18 | Gemak Trust V. Jempak Corporation Et Al (Patent) | Ottawa | 15 d |
| Apr 28, 2025 | T-1184-21 | Adeia Guides, Inc. Et Al. V. Bce Inc. Et Al. (Patent) | Toronto | 21 d |
| Apr 28, 2025 | T-1730-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Pharma Corporation (Patent) | Toronto | 9 d |
| Apr 28, 2025 | T-1731-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Phamra Corporation (Patent) | Toronto | 9 d |
| May 12, 2025 | T-1775-23 | Amgen Canada Inc.et Al. V. Natco Pharma (canada) Inc. (Patent) | To be determined (TrialJA) | 19 d |
| May 12, 2025 | T-1777-23 | Amgen Canada Inc Et Al V. Dr. Reddy's Laboratories Ltd. (Patent) | To be determined (TrialJA) | 19 d |
| May 15, 2025 | T-1731-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Phamra Corporation (Patent) | Toronto | 1 d |
| May 15, 2025 | T-1730-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Pharma Corporation (Patent) | Toronto | 1 d |
| May 21, 2025 | T-1288-18 | Gemak Trust V. Jempak Corporation Et Al (Patent) | Ottawa | 3 d |
| May 26, 2025 | T-732-22 | Pharmascience Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*) | Toronto | 10 d |
| May 26, 2025 | T-2137-23 | Bayer Inc. Et Al. V. Amgen Canada Inc. (Patent) | Toronto | 10 d |
| Jun 2, 2025 | T-1184-21 | Adeia Guides, Inc. Et Al. V. Bce Inc. Et Al. (Patent) | Toronto | 3 d |
| Jun 11, 2025 | T-1775-23 | Amgen Canada Inc.et Al. V. Natco Pharma (canada) Inc. (Patent) | To be determined (TrialJA) | 2 d |
| Jun 11, 2025 | T-1777-23 | Amgen Canada Inc Et Al V. Dr. Reddy's Laboratories Ltd. (Patent) | To be determined (TrialJA) | 2 d |
| Jun 11, 2025 | T-2137-23 | Bayer Inc. Et Al. V. Amgen Canada Inc. (Patent) | Toronto | 2 d |
| Jun 12, 2025 | T-732-22 | Pharmascience Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*) | Toronto | 1 d |
| Jun 23, 2025 | T-1939-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 16 d |
| Jun 23, 2025 | T-1940-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 16 d |
| Jun 23, 2025 | T-2011-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co., Ltd (Patent) | Toronto | 14 d |
| Jul 16, 2025 | T-2011-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co., Ltd (Patent) | Toronto | 2 d |
| Jul 22, 2025 | T-1939-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 3 d |
| Jul 22, 2025 | T-1940-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 3 d |
| Aug 11, 2025 | T-2145-23 | Otsuka Pharmaceutical Co., Ltd V Pharmascience Inc. (Patent) | Toronto | 8 d |
| Aug 18, 2025 | T-1917-23 | Bayer Inc And Regeneron Pharmaceuticals, Inc V. Amgen Canada Inc (Patent) | Toronto | 10 d |
| Aug 18, 2025 | T-1918-23 | Bayer Inc Et Al., V. Amgen Canada Inc (Patent) | Toronto | 10 d |
| Aug 25, 2025 | T-2145-23 | Otsuka Pharmaceutical Co., Ltd V Pharmascience Inc. (Patent) | Toronto | 2 d |
| Sep 2, 2025 | T-1737-23 | Otsuka Pharmaceutical Co., Ltd. V. Jamp Pharma Corporation (Patent) | Toronto | 9 d |
| Sep 2, 2025 | T-2751-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc (Patent) | Toronto | 12 d |
| Sep 2, 2025 | T-1917-23 | Bayer Inc And Regeneron Pharmaceuticals, Inc V. Amgen Canada Inc (Patent) | Toronto | 2 d |
| Sep 2, 2025 | T-1918-23 | Bayer Inc Et Al., V. Amgen Canada Inc (Patent) | Toronto | 2 d |
| Sep 8, 2025 | T-351-24 | Aralez Pharmaceuticals Canada Inc. V. Taro Pharmaceuticals Inc. Et Al. (Patent) | To be determined (TrialJA) | 5 d |
| Sep 15, 2025 | T-1737-23 | Otsuka Pharmaceutical Co., Ltd. V. Jamp Pharma Corporation (Patent) | Toronto | 1 d |
| Sep 19, 2025 | T-351-24 | Aralez Pharmaceuticals Canada Inc. V. Taro Pharmaceuticals Inc. Et Al. (Patent) | To be determined (TrialJA) | 1 d |
| Sep 22, 2025 | T-47-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 8 d |
| Sep 22, 2025 | T-48-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 8 d |
| Sep 25, 2025 | T-2751-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc (Patent) | Ottawa | 2 d |
| Oct 6, 2025 | T-47-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 2 d |
| Oct 6, 2025 | T-48-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 2 d |
| Oct 27, 2025 | T-156-24 | Viiv Healthcare Company Et Al. V. Pharmascience Inc. (Patent) | Toronto | 10 d |
| Nov 12, 2025 | T-1779-23 | Samsung Bioepis Co., Ltd V. Alexion Pharmaceuticals, Inc. (Copyright) | Toronto | 28 d |
| Nov 12, 2025 | T-1584-23 | Amgen Canada Inc. V. Alexion Pharmaceuticals, Inc. (Patent) | Toronto | 28 d |
| Nov 12, 2025 | T-156-24 | Viiv Healthcare Company Et Al. V. Pharmascience Inc. (Patent) | Toronto | 2 d |
| Nov 12, 2025 | T-296-24 | Bayer Inc. Et Al. V. Natco Pharma (canada) Inc. Et Al. (Patent) | Ottawa | 11 d |
| Nov 17, 2025 | T-2148-23 | Outsuka Pharmaceutical Co. Ltd. V. Pharmascience Inc. (Patent) | Toronto | 10 d |
| Nov 24, 2025 | T-91-20 | University Of Saskatchewan Et Al. V. Newagco Inc. Et Al. (Patent) | Toronto | 8 d |
| Nov 24, 2025 | T-938-24 | Viiv Healthcare Company Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 12 d |
| Nov 27, 2025 | T-297-24 | Bayer Inc. Et Al V. Natco Pharma (canada) Inc. Et Al (Patent) | Ottawa | 12 d |
| Dec 1, 2025 | T-675-24 | Pfizer Canada Ulc Et Al. V. Glenmark Pharmaceuticals Canada Inc. Et Al. (Patent) | To be determined (TrialJA) | 10 d |
| Dec 8, 2025 | T-91-20 | University Of Saskatchewan Et Al. V. Newagco Inc. Et Al. (Patent) | Toronto | 2 d |
| Dec 15, 2025 | T-938-24 | Viiv Healthcare Company Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 3 d |
| Jan 7, 2026 | T-745-24 | Viiv Healthcare Company Et Al V. Sandoz Canada Inc. (Patent) | Toronto | 8 d |
| Jan 19, 2026 | T-1336-23 | Boehringer Ingelheim (canada Ltd.) Et Al. V. Auro Pharma Inc. (Patent - Nintedanib*) | Toronto | 10 d |
| Jan 22, 2026 | T-745-24 | Viiv Healthcare Company Et Al V. Sandoz Canada Inc. (Patent) | Toronto | 2 d |
| Feb 2, 2026 | T-1322-24 | Hoffmann-la Roche Limited Et Al. V. Dr. Reddy's Laboratories Sa (Patent - Rituximab*) | To be determined (TrialJA) | 8 d |
| Feb 5, 2026 | T-1336-23 | Boehringer Ingelheim (canada Ltd.) Et Al. V. Auro Pharma Inc. (Patent - Nintedanib*) | Toronto | 2 d |
| Feb 16, 2026 | T-1322-24 | Hoffmann-la Roche Limited Et Al. V. Dr. Reddy's Laboratories Sa (Patent - Rituximab*) | To be determined (TrialJA) | 2 d |
| Mar 2, 2026 | T-1583-24 | Novartis Pharmaceuticals Canada Inc. V. Apotex Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 8 d |
| Mar 2, 2026 | T-1584-24 | Novartis Pharmaceuticals Canada Inc. V. Apotex Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 8 d |
| Mar 16, 2026 | T-1321-24 | Lundbeck Canada Inc. Et Al. V. Jamp Pharma Corporation (Patent - Vortioxetine*) | To be determined (TrialJA) | 8 d |
| Mar 16, 2026 | T-1583-24 | Novartis Pharmaceuticals Canada Inc. V. Apotex Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 2 d |
| Mar 16, 2026 | T-1584-24 | Novartis Pharmaceuticals Canada Inc. V. Apotex Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 2 d |
| Mar 30, 2026 | T-1321-24 | Lundbeck Canada Inc. Et Al. V. Jamp Pharma Corporation (Patent - Vortioxetine*) | To be determined (TrialJA) | 2 d |
| Apr 27, 2026 | T-1770-24 | Novartis Pharmaceuticals Canada Inc. Et Al V. Pharmascience Inc. (Patent - Nilotinib*) | To be determined (TrialJA) | 6 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Oct 10, 2024 | T-1706-23 | 2k4 Inc. O/a Indican Pictures V. Indiecan Entertainment Inc. | Trade Mark - Passing Off | Ottawa | 1 d |
| Oct 22, 2024 | T-624-24 | G6 Hospitality Ip Llc V. Sandals Resorts International 2000 Inc. | Trade Mark - Appeal of a decision of the Registrar | Toronto | 3 h |
| Oct 31, 2024 | T-571-23 | Best Brains Inc. V. Priyadharishini Balasingham Dba Best Brains Tutors | Intellectual Property - Other matters | Toronto | 2 h |
| Dec 2, 2024 | T-340-22 | Vermillion Networks Inc. V. Cenovus Energy Inc. | Trade Mark - Appeal of a decision of the Registrar | Toronto | 5 d |
| Dec 16, 2024 | T-4-24 | The University Of British Columbia V Sage Dining Services Inc | Trade Mark Opposition | Ottawa | 1 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location |
| Sep 3, 2024 | A-2-23 | Marshall Macciacchera Dba Smoothstreams.tv Et Al V. Bell Media Inc Et Al | Appeal (S.27 - Interloc.) - Copyright Act [from T-1257-22 - Copyright Infringement] | Ottawa |
| Sep 3, 2024 | A-262-22 | Marshall Macciacchera Et Al V. Bell Media Inc. Et Al | Appeal (S.27 - Interloc.) - Trade-marks Act [from T-1257-22 - Copyright Infringement] | Ottawa |
| Sep 4, 2024 | A-206-24 | Ge Renewable Energy Canada Inc. V. Canmec Industrial Inc. Et Al. | Appeal (S.27 - Interloc.) - Others [from T-1471-21 - Copyright Infringement [Actions]] | Ottawa |
| Sep 9, 2024 | A-84-24 | Seismotech Ip Holdings Inc. Et Al V. Rona Inc. Et Al | Appeal (S.27 - Interloc.) - Others [from T-1146-23 - Patent Infringement] | Vancouver |
| Sep 12, 2024 | A-277-23 | Seismotech Ip Holdings Inc. Et Al. V. Ecobee Technologies Ulc | Appeal (S.27 - Interloc.) - Patent Act | Vancouver |
| Sep 12, 2024 | A-352-23 | Seismotech Ip Holdings Inc. Et Al. V. Ecobee Technologies Ulc Et Al. | Appeal (S.27 - Interloc.) - Patent Act [from T-1147-23 - Patent Infringement] | Vancouver |
| Oct 1, 2024 | A-88-23 | Wiseau Studio, Llc V Richard Harper Et Al | Appeal (S.27 - Final) - Copyright Act | Ottawa |
| Oct 2, 2024 | A-252-23 | 2474234 Ontario Inc. Et Al V. Dunn's Famous International Holdings Inc. | Appeal (S.27 - Final) - Trade-marks Act [from T-1397-16 - Trade Mark Infringement] | Ottawa |
| Oct 9, 2024 | A-249-22 | Double Diamond Distribution Ltd. V. Crocs Canada, Inc. Et Al | Appeal (S.27 - Final) - Others [from T-1662-17 - Trade Mark Infringement] | Ottawa |
| Oct 9, 2024 | A-322-23 | Socan V. Siriusxm Canada Inc. | S.28 Copyright Board | Toronto |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.